Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes-Reference-Cited by-同舟云学术

Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes

Published:2016-05-24 Issue:4 Volume:64 Page:1388-1389
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lonardo A.¹,Byrne C.D.²,Caldwell S.H.³,Cortez-Pinto H.⁴,Targher G.⁵

Affiliation:

1. Internal Medicine and Outpatient Liver Clinic; NOCSAE Baggiovara; Azienda USL di Modena Modena Italy

2. Nutrition and Metabolism; University of Southampton, Southampton National Institute for Health Research Biomedical Research Centre; Southampton UK

3. Division of Gastroenterology & Hepatology; University of Virginia; Charlottesville VA

4. Department of Gastroenterology; University Hospital of Santa Maria; Lisbon Portugal

5. Section of Endocrinology, Diabetes and Metabolism, Department of Medicine; University of Verona and Azienda Ospedaliera Universitaria Integrata di Verona; Verona Italy

Publisher

Wiley

Subject

Hepatology

Reference5 articles.

1. Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes;Younossi;Hepatology,2016

2. Nonalcoholic fatty liver disease is associated with an almost two-fold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis;Ballestri;J Gastroenterol Hepatol,2015

3. NAFLD: a multisystem disease;Byrne;J Hepatol,2015

4. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity;Musso;Ann Med,2011

5. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups;Lonardo;Dig Liver Dis,2015

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of Four Surrogate Insulin Resistance Indexes with Non-alcoholic Steatohepatitis in Chinese Patients with Obesity;2024-01-11

2. Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions;Cureus;2023-12-04

3. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction;Journal of Ethnopharmacology;2023-12

4. Characterisation of forkhead box protein A3 as a key transcription factor for hepatocyte regeneration;JHEP Reports;2023-12

5. Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis;Biomedicines;2023-11-14